Perspectives post-COVID-19 : le point de vue des pneumologues

More than 5 millions of people in France have presented a SARS-CoV-2 infection. In the previous coronavirus epidemics (SARS-CoV, Mers-CoV), patients have developed pulmonary sequelae with dyspnoea, DLCO decrease and/or fibrosis lesions. The purpose of this review was to evaluate the respiratory sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Basille, Damien, Jounieaux, Vincent, Andrejak, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2022
Materias:
Revue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122778/
http://dx.doi.org/10.1016/j.anrea.2022.03.005
Descripción
Sumario:More than 5 millions of people in France have presented a SARS-CoV-2 infection. In the previous coronavirus epidemics (SARS-CoV, Mers-CoV), patients have developed pulmonary sequelae with dyspnoea, DLCO decrease and/or fibrosis lesions. The purpose of this review was to evaluate the respiratory sequelae and to do a summary of the main respiratory symptoms after a COVID-19 infection and their aetiologies. The four main causes of dyspnoea are respiratory sequelae, deconditioning, hyperventilation and classical causes of dyspnoea. The main respiratory sequelae were DLCO alteration and fibrosis pattern. Actually, the prevalence of these respiratory sequelae is unknown.

Ejemplares similares